Decisions 29th November 2016


At the meeting that took place on 29th November, the folllowing decisions were agreed.

 

New Drug Requests

Approved

Feraccru

  • Approved for inclusion on the formulary for 12 months. Audit data to be reviewed after this period

Metvix

  • Approved for inclusion on the formulary if Photodynamic Therapy is approved

Nexobrid

  • Approved to be added to the formulary on confirmation of directorate funding available

Jaydess

  • To be added to the formulary as an alternative for patients that are unable to use Mirena

Not Approved

Guanfacine

  • More evidence required.

Other 

Adrenaline pen review

  • 3 brands to be added

Adjuvant bisphosphonates in Breast Cancer

  • Ibandronate to be added when SCP in available

Fostair Nexthaler

  • To be added for COPD

 

 

Shared Care Protocols/TLS Change in Status

Rufinamide

  • Updated SCP approved

Riluzole

  • Update SCP approved

Azathioprine

  • Dermatology oralmucosal updates approved

 

Last updated by: on 20-12-2016 18:36